Track Treace Medical Concepts, Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Treace Medical Concepts, Inc. TMCI · Stock Open Treace Medical Concepts, Inc. in new tab

5.27 USD
EPS
-0.85
P/B
5.06
ROE
-71.99
Beta
1.56
Target Price
6.17 USD
Loading chart...
Key Metrics
Earnings dateFeb. 26, 2027
EPS-0.85
Book Value1.04
Price to Book5.06
Debt/Equity107.84
% Insiders25.235%
Growth
Revenue Growth-0.04%
Estimates
Forward P/E-6.20
Forward EPS-0.85
Target Mean Price6.17

DCF valuation

Model fair value for Treace Medical Concepts, Inc. (TMCI)
Result
Sign in to run the valuation for TMCI.
Assumptions
Growth– Capex– Tax– Terminal g– Cost of equity– Cost of debt–
Analyst price targets
3 analysts · consensus Buy · mean target 6.17 USD (low 5.00, high 7.00) · as of 14 Nov 2026
Low 5.00
Mean 6.17
High 7.00
Price 5.27
Published broker research as supplied by our market data feed, named by firm and dated; it does not identify individual analysts. Targets carry their last refresh date; rating changes can be a few days behind.

Treace Medical Concepts, Inc. Logo Treace Medical Concepts, Inc. Analysis (TMCI)

United States Health Care Official Website Stock

Is Treace Medical Concepts, Inc. a good investment? Treace Medical Concepts, Inc. (TMCI) is currently trading at 5.27 USD. Market analysts have a consensus price target of 6.17 USD. This suggests a potential upside from current levels.

Earnings Schedule: Treace Medical Concepts, Inc. is expected to release its next earnings report on Feb. 26, 2027. The market consensus estimate for Forward EPS is -0.85.

Investor FAQ

Does Treace Medical Concepts, Inc. pay a dividend?

No, it does not currently pay a dividend.

What asset class is Treace Medical Concepts, Inc.?

Treace Medical Concepts, Inc. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

When is the next earnings date?

The next earnings date is projected to be Feb. 26, 2027. The company currently has a trailing EPS of -0.85.

Company Profile

Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty System, enables surgeons to correct all three dimensions of the bunion deformity, stabilize the first TMT joint, and allow return to weight-bearing in a walking boot; minimally invasive products for four bunion classes; Nanoplasty 3D Minimally Invasive Bunion Correction System delivers a reproducible 3D correction of the bunion deformity through a cosmetically appealing; and Percuplasty Percutaneous 3D Bunion Correction System that provides 3D correction of the bunion deformity through percutaneous incisions. It also provides Adductoplasty System, a system designed for the correction of metatarsus adductus deformities and osteoarthritis of the midfoot; SpeedMTP Rapid Compression Implant; SpeedPlate Implant Fixation Platform to address the fusion of larger bones of the midfoot and rearfoot; SpeedPlate Micro-Quad implant, an implant designed for stability and fit in small incision surgical approaches; and SpeedAkin Anatomic Compression Implant. In addition, the company offers The IntelliGuide patient specific instrumentation provides patient-specific, 3D-printed cut guides, and a pre-operative plan for a complete picture of the deformity and correction. Further, it provides FastGrafter Autografter Harvesting System; SpeedRelease Guided Release Instrument; TriTome Triple-Edge Release Instrument; RazorTome 7mm Precision Osteotome; LapiTome Hooked Bone Removal Osteotome; GreatRelease Rapid MTP Release Instrument; CornerChisel Release Tool; NanoRasp MIS Bone Contouring Tool; FeatherRasp Rapid Bone Contouring Instrument; and Akinator Single-cut Akin Wedge Osteotomy tool. Additionally, the company offers biologics and wedges, such as Treace Allograft Wedges; and CortiFuse Flowable Cortical Fibers. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.

Exchange Ticker
NMS (United States) TMCI
Trades
No dividend information available for this instrument.
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion